(Q37785808)

23 August 2017

title

Medical therapies for meningiomas (English)

1 reference

23 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20820875

7 July 2024

1

Patrick Y Wen

1 reference

23 August 2017

4

Rameen Beroukhim

1 reference

23 August 2017

Eudocia Quant

2

1 reference

23 August 2017

Jan Drappatz

3

1 reference

23 August 2017

Andrew D. Norden

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20820875

7 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20820875

7 July 2024

publication date

4 September 2010

1 reference

full work available at URL

23 August 2017

http://link.springer.com/content/pdf/10.1007/s11060-010-0349-8.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/S11060-010-0349-8

http://link.springer.com/article/10.1007/s11060-010-0349-8/fulltext.html

7 July 2024

1 reference

https://api.crossref.org/works/10.1007/S11060-010-0349-8

http://link.springer.com/content/pdf/10.1007/s11060-010-0349-8

7 July 2024

1 reference

https://api.crossref.org/works/10.1007/S11060-010-0349-8

Journal of Neuro-Oncology

7 July 2024

published in

1 reference

23 August 2017

volume

99

1 reference

23 August 2017

issue

3

1 reference

23 August 2017

page(s)

365-378

1 reference

Nonsurgical treatment options in the management of intracranial meningiomas

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0349-8

Natural history of conservatively treated meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0349-8

Temozolomide for treatment-resistant recurrent meningioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0349-8

Meningioma pathology, genetics, and biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0349-8

Nervous system neoplasms and primary malignancies of other sites. The unique association between meningiomas and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0349-8

Role of antiprogestational therapy for meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0349-8

Molecular genetics of meningiomas: from basic research to potential clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0349-8

Establishment of an in vivo meningioma model with human telomerase reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0349-8

Epidermal growth factor receptor family (EGFR, ErbB2-4) in gliomas and meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0349-8

Combining radiation and molecular targeting in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0349-8

Hydroxyurea for treatment of meningioma

21 January 2018

1 reference

12 December 2020

Effect of treatment with pegvisomant on meningioma growth in vivo

1 reference

12 December 2020

Epidermal growth factor receptor expression in 72 meningiomas

1 reference

12 December 2020

The biology of meningiomas

1 reference

12 December 2020

Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea

1 reference

12 December 2020

A novel model of intracranial meningioma in mice using luciferase-expressing meningioma cells. Laboratory investigation

1 reference

12 December 2020

Progesterone and estrogen receptors in meningiomas: prognostic considerations.

1 reference

12 December 2020

Evidence for phosphatidylinositol 3-kinase-Akt-p7S6K pathway activation and transduction of mitogenic signals by platelet-derived growth factor in meningioma cells

1 reference

12 December 2020

Oncological implications of hypoxia inducible factor-1alpha (HIF-1alpha) expression

1 reference

12 December 2020

Growth of a meningioma in a transsexual patient after estrogen-progestin therapy

1 reference

12 December 2020

Is there an association between meningioma and hormone replacement therapy?

1 reference

12 December 2020

Expression and activation of epidermal growth factor receptors in meningiomas

1 reference

12 December 2020

Molecular biology of unreresectable meningiomas: implications for new treatments and review of the literature

1 reference

12 December 2020

Different activation of mitogen-activated protein kinase and Akt signaling is associated with aggressive phenotype of human meningiomas

1 reference

12 December 2020

The treatment of recurrent unresectable and malignant meningiomas with interferon alpha-2B

1 reference

12 December 2020

Mifepristone (RU 486) treatment of meningiomas

1 reference

12 December 2020

Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs

1 reference

12 December 2020

Progesterone-receptor index in meningiomas: correlation with clinico-pathological parameters and review of the literature

1 reference

12 December 2020

Exogenous hormone use and meningioma risk: what do we tell our patients?

1 reference

12 December 2020

Histone deacetylase inhibitors: multifunctional anticancer agents.

1 reference

12 December 2020

Therapeutic aspects of chaperones/heat-shock proteins in neuro-oncology

1 reference

12 December 2020

Apoptosis, Bcl-2 antisense, and cancer therapy

1 reference

12 December 2020

Induction of apoptosis in primary meningioma cultures by fenretinide

1 reference

12 December 2020

Molecular mechanisms of glioma invasiveness: the role of proteases

1 reference

12 December 2020

Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations

1 reference

12 December 2020

Expression and localization of endothelin-1 and endothelin receptors in human meningiomas. Evidence for a role in tumoral growth

1 reference

12 December 2020

Hydroxyurea chemotherapy for meningiomas: enlarged cohort with extended follow-up

1 reference

12 December 2020

New prospects for management and treatment of inoperable and recurrent skull base meningiomas

1 reference

12 December 2020

Radiological response in an incidental meningioma in a patient treated with chemotherapy combined with CP-751,871, an IGF-1R inhibitor

1 reference

12 December 2020

Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics

1 reference

12 December 2020

Human meningiomas co-express platelet-derived growth factor (PDGF) and PDGF-receptor genes and their protein products

1 reference

12 December 2020

Targeting apoptosis pathways in cancer therapy

1 reference

12 December 2020

IAP-targeted therapies for cancer

1 reference

12 December 2020

Inhibition of angiogenesis and growth of human non-malignant and malignant meningiomas by TNP-470.

1 reference

12 December 2020

Cyclin-dependent kinase pathways as targets for cancer treatment

1 reference

12 December 2020

Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08).

1 reference

12 December 2020

Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors. Part 5: apoptosis and cell cycle

1 reference

12 December 2020

Cyclin-dependent kinase inhibitors as anticancer drugs.

1 reference

12 December 2020

Platelet-derived growth factor in human brain tumors

1 reference

12 December 2020

Intracranial meningiomas: diagnosis and treatment

1 reference

12 December 2020

A phase II trial of PTK787/ZK 222584 in recurrent or progressive radiation and surgery refractory meningiomas.

1 reference

12 December 2020

Intracerebral Meningiomas

1 reference

12 December 2020

Expression and localization of placenta growth factor and PlGF receptors in human meningiomas

1 reference

12 December 2020

The PI3K pathway as drug target in human cancer

1 reference

12 December 2020

New Approaches for the Treatment of Refractory Meningiomas

1 reference

12 December 2020

Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone

1 reference

12 December 2020

Alpha(v)beta3 and alpha(v)beta5 integrin expression in meningiomas

1 reference

12 December 2020

Molecular pathways triggering glioma cell invasion

1 reference

12 December 2020

Irinotecan: a potential new chemotherapeutic agent for atypical or malignant meningiomas

1 reference

12 December 2020

Nelfinavir potentiation of imatinib cytotoxicity in meningioma cells via survivin inhibition

1 reference

12 December 2020

Characterization of the epidermal growth factor receptor in human meningioma

1 reference

12 December 2020

Hydroxyurea chemotherapy in the treatment of meningiomas

1 reference

12 December 2020

Chronic suppressive therapy with calcium channel antagonists for refractory meningiomas

1 reference

12 December 2020

Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse

1 reference

12 December 2020

Treatment of high risk or recurrent meningiomas with hydroxyurea

1 reference

12 December 2020

New opportunities in chemosensitization and radiosensitization: modulating the DNA-damage response

1 reference

12 December 2020

A phase II evaluation of tamoxifen in unresectable or refractory meningiomas: a Southwest Oncology Group study

1 reference

12 December 2020

Expression of somatostatin receptor mRNA in human meningiomas and their implication in in vitro antiproliferative activity.

1 reference

12 December 2020

Mitogenic signal transduction pathways in meningiomas: novel targets for meningioma chemotherapy?

1 reference

12 December 2020

Targeting PI3K signalling in cancer: opportunities, challenges and limitations

1 reference

12 December 2020

Methylation status of MGMT gene promoter in meningiomas

1 reference

12 December 2020

Cilengitide: an integrin-targeting arginine-glycine-aspartic acid peptide with promising activity for glioblastoma multiforme

1 reference

12 December 2020

Transforming growth factor-beta effects on meningioma cell proliferation and signal transduction pathways

1 reference

12 December 2020

Meningiomas: role of vascular endothelial growth factor/vascular permeability factor in angiogenesis and peritumoral edema.

1 reference

12 December 2020

The role of focal-adhesion kinase in cancer - a new therapeutic opportunity

1 reference

12 December 2020

Reapprasial of the role of endocrine therapy in meningioma management.

1 reference

12 December 2020

Diagnosis and treatment of atypical and anaplastic meningiomas: a review

1 reference

12 December 2020

Different distribution of c-myc and MIB-1 positive cells in malignant meningiomas with reference to TGFs, PDGF, and PgR expression

1 reference

12 December 2020

Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases.

1 reference

12 December 2020

Molecular targets of glioma invasion.

1 reference

12 December 2020

Coexpression of hepatocyte growth factor/scatter factor (HGF/SF) and its receptor cMET predict recurrence of meningiomas

1 reference

12 December 2020

Recurrent meningioma: salvage therapy with long-acting somatostatin analogue

1 reference

12 December 2020

Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathway

1 reference

12 December 2020

The epidermal growth factor receptor is associated with phospholipase C-gamma 1 in meningiomas

1 reference

12 December 2020

Vascular endothelial growth factor, hepatocyte growth factor/scatter factor, basic fibroblast growth factor, and placenta growth factor in human meningiomas and their relation to angiogenesis and malignancy

1 reference

12 December 2020

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma

1 reference

12 December 2020

Antitumor activity of the growth hormone receptor antagonist pegvisomant against human meningiomas in nude mice

1 reference

12 December 2020

1 reference

12 December 2020

1 reference

12 December 2020

A high ratio of insulin-like growth factor II/insulin-like growth factor binding protein 2 messenger RNA as a marker for anaplasia in meningiomas.

1 reference

12 December 2020

Inhibition of the growth of cultured human meningioma cells by recombinant interferon-α

1 reference

12 December 2020

Reproductive factors and risk of meningioma and glioma.

1 reference

12 December 2020

Biology of meningiomas

1 reference

12 December 2020

Endothelins are angiogenic

1 reference

12 December 2020

Angiogenesis inhibitors: current strategies and future prospects

1 reference

12 December 2020

Brain edema in meningiomas is associated with increased vascular endothelial growth factor expression.

1 reference

12 December 2020

Association between absence of epidermal growth factor receptor immunoreactivity and poor prognosis in patients with atypical meningioma

1 reference

12 December 2020

Novel medical therapeutics in glioblastomas, including targeted molecular therapies, current and future clinical trials

1 reference

12 December 2020

Novel therapies for meningiomas

1 reference

12 December 2020

Expression of endothelin(A) receptors in human gliomas and meningiomas, with high affinity for the selective antagonist PD156707.

1 reference

12 December 2020

Phase I clinical evaluation of a neutralizing monoclonal antibody against epidermal growth factor receptor in advanced brain tumor patients: preliminary study

1 reference

12 December 2020

uPA/uPAR downregulation inhibits radiation-induced migration, invasion and angiogenesis in IOMM-Lee meningioma cells and decreases tumor growth in vivo

1 reference

12 December 2020

Chemotherapy for meningiomas

1 reference

12 December 2020

The Src signaling pathway: a potential target in melanoma and other malignancies

1 reference

12 December 2020

Expression of IGF-II, IGFBP-2, -5, and -6 in meningiomas with different brain invasiveness

1 reference

12 December 2020

Adjuvant combined modality therapy for malignant meningiomas

1 reference

12 December 2020

TGF alpha expression in meningioma--tumor progression and therapeutic response

1 reference

12 December 2020

Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma

1 reference

12 December 2020

Evidence for mitogen-associated protein kinase activation and transduction of mitogenic signals by platelet-derived growth factor in human meningioma cells

1 reference

12 December 2020

Expression of PDGF β-receptors in human meningioma cells

1 reference

12 December 2020

Targeted induction of apoptosis in cancer management: the emerging role of tumor necrosis factor-related apoptosis-inducing ligand receptor activating agents

1 reference

12 December 2020

SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile

1 reference

12 December 2020

Long-term administration of mifepristone (RU486): clinical tolerance during extended treatment of meningioma.

1 reference

12 December 2020

Meningiomas in 2009: controversies and future challenges

1 reference

12 December 2020

Salvage chemotherapy with CPT-11 for recurrent meningioma

1 reference

12 December 2020

1 reference

12 December 2020

Molecular pathogenesis of meningiomas.

1 reference

12 December 2020

Intracranial injection of human meningioma cells in athymic mice: an orthotopic model for meningioma growth

1 reference

12 December 2020

MIB-1 (Ki-67) index and transforming growth factor-alpha (TGF alpha) immunoreactivity are significant prognostic predictors for meningiomas.

1 reference

12 December 2020

Restoration of tissue factor pathway inhibitor inhibits invasion and tumor growth in vitro and in vivo in a malignant meningioma cell line.

1 reference

12 December 2020

Chemotherapy, hormonal therapy, and immunotherapy for recurrent meningiomas.

1 reference

12 December 2020

Advances in meningioma therapy

1 reference

12 December 2020

Autocrine growth stimulation of human meningioma cells by platelet-derived growth factor

1 reference

12 December 2020

The TRAIL apoptotic pathway in cancer onset, progression and therapy

1 reference

12 December 2020

Antiestrogenic therapy of meningiomas--a pilot study.

1 reference

12 December 2020

Detection of epidermal growth factor and transforming growth factor alpha protein in meningiomas and other tumors of the central nervous system in human beings

1 reference

12 December 2020

Expression of matrix metalloproteinases, their inhibitors, and urokinase plasminogen activator in human meningiomas.

1 reference

12 December 2020

Antiangiogenics: the potential role of integrating this novel treatment modality with chemoradiation for solid cancers

1 reference

12 December 2020

Neuroendocrine tumors in the brain

1 reference

12 December 2020

Characterization of 68Ga-DOTA-D-Phe1-Tyr3-octreotide kinetics in patients with meningiomas.

1 reference

12 December 2020

Meningioma: current treatment options and future directions

1 reference

12 December 2020

Diagnosing and exploiting cancer's addiction to blocks in apoptosis

1 reference

12 December 2020

Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma.

1 reference

12 December 2020

Expression of the JAK and STAT superfamilies in human meningiomas

1 reference

12 December 2020

Interferon-alpha for recurrent World Health Organization grade 1 intracranial meningiomas

1 reference

12 December 2020

Farnesyltransferase inhibitors

1 reference

12 December 2020

Incidence of intracranial meningiomas in Denmark, Finland, Norway and Sweden, 1968-1997.

1 reference

12 December 2020

Enhanced cell killing induced by the combination of radiation and the heat shock protein 90 inhibitor 17-allylamino-17- demethoxygeldanamycin: a multitarget approach to radiosensitization

1 reference

12 December 2020

An inhibitor of Bcl-2 family proteins induces regression of solid tumours

1 reference

12 December 2020

Hormonal exposures and the risk of intracranial meningioma in women: a population-based case-control study

1 reference

12 December 2020

Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis

1 reference

12 December 2020

Expression of PDGF and its receptor as well as their relationship to proliferating activity and apoptosis of meningiomas in human meningiomas

1 reference

12 December 2020

Clinical use of octreotide in unresectable meningiomas. A report of three cases

1 reference

12 December 2020

An orthotopic skull base model of malignant meningioma.

1 reference

12 December 2020

1 reference

12 December 2020

Histological classification and molecular genetics of meningiomas

1 reference

12 December 2020

Meningioma treated with interferon-alpha, evaluated with [(11)C]-L-methionine positron emission tomography

1 reference

12 December 2020

Expression of matrix metalloproteinases 2 and 9 in meningiomas associated with different degrees of brain invasiveness and edema.

1 reference

12 December 2020

Non-resectable slow-growing meningiomas treated by hydroxyurea

1 reference

12 December 2020

Somatostatin receptor scintigraphy in postsurgical follow-up examinations of meningioma

1 reference

12 December 2020

Gastrosplenic fistula from Hodgkin's lymphoma

31

1 reference

https://api.crossref.org/works/10.1007/S11060-010-0349-8

Cilengitide: an integrin-targeting arginine-glycine-aspartic acid peptide with promising activity for glioblastoma multiforme.

7 July 2024

140

1 reference

https://api.crossref.org/works/10.1007/S11060-010-0349-8

Small molecule inhibition of hypoxia inducible factor-1alpha: a viable therapeutic approach?

7 July 2024

152

1 reference

https://api.crossref.org/works/10.1007/S11060-010-0349-8

7 July 2024

Identifiers

1 reference

23 August 2017

1 reference